Elsevier New York United States of America United Kingdom

Elsevier announces expansion to their flagship clinical decision support solution, ClinicalKey AI

with the American College of Cardiology (ACC) announced earlier this year, which made the ACC's Clinical Practice Guidelines and Expert Consensus Decision Pathways on a range of cardiology topics available on ClinicalKey AI.

You can learn more about ClinicalKey AI on our website, and also at the upcoming 2025 HIMSS Conference in Las Vegas. Join the Elsevier team at booth 3616 and AI Pavilion Kiosk 121-14 to find out more about ClinicalKey AI. You can also hear from Elsevier spokespeople Dr. Amber Featherstone-Uwague (3:10 p.m., March 4) and Dr. Paul "PJ" Helmuth (2 p.m., March 5) at speaking sessions in the AI Pavillion.

About Elsevier
As a global leader in scientific information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies.

We have supported the work of our research and healthcare communities for more than 140 years. Our 9,500 employees around the world, including 2,500 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work. Our 2,900 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray's Anatomy.

Together with the?Elsevier Foundation, we work in partnership with the communities we serve to advance?inclusion and diversity?in science, research and healthcare in developing countries and around the world. 

Elsevier is part of?RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit www.elsevier.com. 

About iPrescribe by DrFirst
iPrescribe by DrFirst is the industry-leading e-prescribing solution, trusted by healthcare providers throughout the U.S. It enables safe and efficient prescribing of controlled and non-controlled substances anytime, anywhere. Built for mobility and designed to adapt to any workflow, iPrescribe ensures seamless, compliant prescribing across all practice settings. Whether used as a standalone mobile solution or integrated with an EHR, iPrescribe delivers flexibility for in-office and after-hours needs. DrFirst solutions help 100 million patients a year and are used by more than 450,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and over 2,000 hospitals in the U.S. To learn more, visit iPrescribe.com and DrFirst.com.

Logo - https://mma.prnewswire.com/media/2628519/5194789/Elsevier_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/elsevier-announces-expansion-to-their-flagship-clinical-decision-support-solution-clinicalkey-ai-302390584.html